EA = effect allele; OA = other allele; EAF = frequency of effect allele;
| Summary of biological annotations |
| SNP | rs13538 |
| Chromosomal location | Chr2: 73,721,836 (2p13.2) |
| Gene (distance) | NAT8 (0) |
| Predicted causal gene | NAT8 |
| Gene/protein classification | - |
| Metabolite (Pathway) | N-acetylornithine (Urea cycle; arginine-, proline-, metabolism; Amino acid) myo-inositol (Inositol metabolism; Lipid) |
| Biochemical locus-metabolite relationship | NAT8 shows sequence similarity to N-acetyltransferases. N-acetylornithine may be a product or related to a product. Ratio interpretation: possibly related to substrate and product ('activity'). Ornithine itself is part of the urea cycle and myoinositol levels are altered in patients with urea cycle disorders [18662894] |
| eQTL associations | ALMS1 (L), ALMS1 (S) † |
† F = adipose tissue; S = skin cells; L = lymphoblastoid cells; H = liver cells;
| Medical information |
| Complex trait associations | Chronic kidney disease [20383146]; Creatinine levels [20383145]; |
| Known metabolite associations | N-acetylornithine [21886157]; X-12510,X-11787,X-12093 [23093944]; N-ACu [21931564]; |
| Inborn error of metabolism | - |
| Pharmacological information |
| ChEMBL ID | - |
| Drug information |
-
|
| Locus information for top associated metabolite |
HapMap2 imputation | 1KGP imputation |